Generalisation from phase III clinical trials: survival, quality of life, and health economics

Lancet. 1997 Oct 4;350(9083):1025-7. doi: 10.1016/s0140-6736(97)03053-5.
No abstract available

MeSH terms

  • Clinical Trials, Phase III as Topic* / economics
  • Costs and Cost Analysis
  • Economics, Medical*
  • Humans
  • Quality of Life*
  • Quality-Adjusted Life Years
  • Randomized Controlled Trials as Topic* / economics
  • Research Design
  • Therapeutic Human Experimentation*